Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalin

NeuroImmunoModulation

Volumn 11, Issue 3, 2004, Pages 141-148

  Sizemore, Robert C ^a   Piva, Marta ^a   Moore, LeeTerry ^a   Gordonov, Natalia ^a   Heilman, Edward ^b   Godfrey, Henry P ^c  

^a ALCORN STATE UNIVERSITY   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Delayed type hypersensitivity; Enkephalin; Hairless guinea pigs; Tyr Gly; Tyr Gly Gly

Indexed keywords

ENKEPHALIN; FREUND ADJUVANT; METENKEPHALIN; PEPTIDE DERIVATIVE; TUBERCULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GUINEA PIG; IMMUNIZATION; INFLAMMATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SKIN TEST; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; CHEMOTAXIS, LEUKOCYTE; ENKEPHALIN, METHIONINE; GLYCINE; GUINEA PIGS; HYPERSENSITIVITY, DELAYED; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; PEPTIDES; SKIN; TUBERCULIN; TYROSINE;

EID: 1842454890     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076763     Document Type: Article

References (33)

1. Adler R, Felter DL, Cohen N (eds): Psychoneuroimmunology, ed 3. New York, Academic Press, 2001.
2. Blalock JE, Harbour-McMenamin D, Smith EM: Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 1985;135:858s-861s.
3. Blalock JE: Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann NY Acad Sci 1994;741:292-298.
4. Wybran J: Enkephalins and endorphins as modifiers of the immune system: Present and future. Fed Proc 1985;44:92-94.
5. Oleson DR, Johnson DR: Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 1988;2:171-186.
6. Jankovic BD: Enkephalins and immune inflammatory reactions. Acta Neurol (Napoli) 1991;13:433-441.
7. Dubinin KV, Zakharova LA, Khegai LA, Zaitsev SV: Immunomodulating effect of met-enkephalin on different stages of lymphocyte proliferation induced with concanavalin A in vitro. Immunopharmacol Immunotoxicol 1994;16:463-472.
8. Sizemore RC, Dienglewicz RL, Pecunia E, Gottlieb AA: Modulation of concanavalin Ainduced, antigen-nonspecific regulatory cell activity by leu-enkephalin and related peptides. Clin Immunol Immunopathol 1991;60:310-318.
9. Haberstock H, Marotti T: The relevance of intact enkephalin molecule in predominantly δ opioid receptor mediated superoxide anion release. Neuropeptides 1995;29:357-365.
10. Haberstock H, Marotti T, Banfic H: Neutrophil signal transduction in met-enkephalin modulated superoxide anion release. Neuropeptides 1996;30:193-201.
11. Kayser H, Meisel H: Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett 1996;383:18-20.
12. Sinha SK, Sizemore RC, Gottlieb AA: Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic. Biotechnology 1988;6:810-815.
13. Cobb A, Moore L, Godfrey HP, Gordonov N, Heilman E, Sizemore RC: The use of hairless (IAF/HA-HO) guinea pigs for the determination of delayed-type hypersensitivity to tuberculin. Int Immunopharmacol 2001;1:349-353.
14. Sizemore RC, Kern CH, Gottlieb MS, Gottlieb AA: A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: A measure of the immunopotentiation of cell-mediated immunity. Clin Immunol Immunopathol 1995;76:308-313.
15. Godfrey HP, Feng Z, Mandy S, Mandy K, Huygen K, De Bruyn J, Abou-Zeid C, Wiker HG, Nagai S, Tasaka H: Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins. Infect Immun 1992;60:2522-2528.
16. Modlin RL: Th1-Th2 paradigm: Insights from leprosy. J Invest Dermatol 1994;102:828-832.
17. McGuirk P, Mills KHG: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002;23:450-455.
18. Salzet M: Neuroimmunology of opioids from invertebrates to human. Neuroendocrinol Lett 2001;22:467-474.
19. Jankovic BD, Maric D: Enkephalins modulate in vivo immune reactions through δ- and μ-opioid receptors. Ann NY Acad Sci 1988;540:691-693.
20. Carr DJ, DeCosta BR, Kim CH, Jacobson AE, Guarcello V, Rice KC, Blalock JE: Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes. J Endocrinol 1989;122:161-168.
21. Gilmore W, Weiner LP: The opioid specificity of β-endorphin enhancement of murine lymphocyte proliferation. Immunopharmacology 1989;17:19-30.
22. 2+ modulation in human B cell lines. J Immunol 1992;149:4074-4081.
23. Malick JB, Bell RMS (eds): Endorphins: Chemistry, Physiology, Pharmacology and Clinical Relevance. New York, Dekker, 1982.
24. Wybran J, Schandene L, Van Vooren JP, Vandermoten G, Latinne D, Sonnet J, De Bruyère M, Taelman H, Plotnikoff NP: Immunologic properties of methionine-enkephalin, and therapeutic implications in AIDS, ARC, and cancer. Ann NY Acad Sci 1987;496:108-114.
25. Bowes MA, Kenny AJ: An immunohistochemical study of endopeptidase-24.11 and aminopeptidase N in lymphoid tissues. Immunology 1987;60:247-253.
26. Beaumont A, Brouet JC, Roques BP: Neutral endopeptidase 24.11 and angiotensin converting enzyme like activity in CALLA positive and CALLA negative lymphoid cells. Biochem Biophys Res Commun 1989;160:1323-1329.
27. Werfel T, Sonntag G, Weber MH, Gotze O: Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991;147:3909-3914.
28. Ansorge S, Schon E, Kunz D: Membranebound peptidases of lymphocytes: Functional implications. Biomed Biochim Acta 1991;50:799-807.
29. Marini M, Urbani A, Bongiorno L, Roda LG: Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines. 3. Soluble enzymes. Int J Immunopharmacol 1992;14:995-1002.
30. Marini M, Urbani A, Bongiorno L, Roda LG: Soluble enkephalin-degrading enzymes released by lymphomic and erythroleukaemic cell lines. Neurochem Res 1992;17:1155-1161.
31. Bongiorno L, Marini M, Urbani A, Ausiello CM, Roda LG: Effect of stimulation on soluble proteolytic enzymes relased by peripheral blood mononuclear cells. Int J Immunopharmacol 1993;15:621-629.
32. de Saint-Vis B, Cupillard L, Pandrau-Garcia D, Ho S, Renard N, Grouard G, Duvert V, Thomas X, Galizzi JP, Bancherea J, Saeland S: Distribution of carboxypeptidase M on lymphoid and myeloid cells parallels the other zinc-dependent proteases CD10 and CD13. Blood 1995;86:1098-1105.
33. Janak PH, Martinez JL: Only tyrosine-containing metabolites of leu-enkephalin impair active avoidance conditioning in mice. Pharmacol Biochem Behav 1990;37:655-659.